ELEVANCE HEALTH, INC. Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments
ELEVANCE HEALTH, INC. (ELV) reported Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments of $341.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments · last filed 2025-02-20
- ELEVANCE HEALTH, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for the quarter ending 2023-03-31 was $342.00M, a 3700.00% increase year-over-year.
- ELEVANCE HEALTH, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for the quarter ending 2022-09-30 was -$21.00M.
- ELEVANCE HEALTH, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for the quarter ending 2022-06-30 was -$80.00M.
- ELEVANCE HEALTH, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for the quarter ending 2022-03-31 was $9.00M.
- ELEVANCE HEALTH, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for fiscal 2023 was $341.00M, a 46.98% increase from fiscal 2022.
- ELEVANCE HEALTH, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for fiscal 2022 was $232.00M.
- ELEVANCE HEALTH, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for fiscal 2021 was -$259.00M.
- ELEVANCE HEALTH, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for fiscal 2019 was -$209.00M.
| Period end | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments 3 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments 3 month as first filed | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments 6 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments 9 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments 9 month as first filed | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments 12 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $341.00M 10-K · filed 2025-02-20 | -$341.00M 10-K · filed 2024-02-21 | |||||
| 2023-03-31 | $342.00M 10-Q · filed 2024-10-17 | -$342.00M 10-Q · filed 2023-04-19 | |||||
| 2022-12-31 | $232.00M 10-K · filed 2025-02-20 | -$232.00M 10-K · filed 2023-02-15 | |||||
| 2022-09-30 | -$21.00M 10-Q · filed 2023-10-18 | -$101.00M derived: sum of 2 quarters · filed 2023-10-18 | -$92.00M derived: sum of 3 quarters · filed 2023-10-18 | ||||
| 2022-06-30 | -$80.00M 10-Q · filed 2023-10-18 | -$71.00M derived: sum of 2 quarters · filed 2023-10-18 | |||||
| 2022-03-31 | $9.00M 10-Q · filed 2023-10-18 | ||||||
| 2021-12-31 | -$259.00M 10-K · filed 2024-02-21 | ||||||
| 2021-09-30 | -$2.00M 10-Q · filed 2022-10-19 | -$218.00M derived: sum of 2 quarters · filed 2022-10-19 | |||||
| 2021-06-30 | -$216.00M 10-Q · filed 2022-10-19 | ||||||
| 2020-12-31 | -$181.00M 10-Q · filed 2023-10-18 | ||||||
| 2020-06-30 | -$82.00M 10-Q · filed 2021-10-20 | -$124.00M derived: sum of 2 quarters · filed 2021-10-20 | |||||
| 2020-03-31 | -$42.00M 10-Q · filed 2021-10-20 | ||||||
| 2019-12-31 | -$209.00M 10-K · filed 2022-02-16 | ||||||
| 2019-06-30 | -$9.00M 10-Q · filed 2020-10-28 | -$61.00M derived: sum of 2 quarters · filed 2020-10-28 | -$303.00M derived: sum of 3 quarters · filed 2021-02-18 | -$368.00M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2019-03-31 | -$52.00M 10-Q · filed 2020-10-28 | -$294.00M derived: sum of 2 quarters · filed 2021-02-18 | -$359.00M derived: sum of 3 quarters · filed 2021-02-18 | -$359.50M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2018-12-31 | -$242.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$307.00M derived: sum of 2 quarters · filed 2021-02-18 | -$307.50M derived: sum of 3 quarters · filed 2021-02-18 | -$337.00M 10-K · filed 2021-02-18 | |||
| 2018-09-30 | -$65.00M 10-Q · filed 2019-10-23 | -$65.50M derived: sum of 2 quarters · filed 2019-10-23 | -$95.00M 10-Q · filed 2018-10-31 | -$339.50M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | -$30.50M 10-Q · filed 2018-07-25 | -$274.50M derived: sum of 3 quarters · filed 2020-02-19 | -$274.40M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-03-31 | -$30.00M 10-Q · filed 2019-10-23 | -$30.30M 10-Q · filed 2018-04-25 | -$274.00M derived: sum of 2 quarters · filed 2020-02-19 | -$273.90M derived: sum of 3 quarters · filed 2020-02-19 | -$273.90M derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2017-12-31 | -$244.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$243.90M derived: sum of 2 quarters · filed 2020-02-19 | -$243.90M derived: sum of 3 quarters · filed 2020-02-19 | -$245.00M 10-K · filed 2020-02-19 | |||
| 2017-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $100.00K derived: sum of 2 quarters · filed 2018-10-31 | -$1.00M 10-Q · filed 2018-10-31 | -$1.10M 10-Q · filed 2017-10-25 | |||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | -$1.10M 10-Q · filed 2018-07-25 | |||||
| 2017-03-31 | -$1.10M 10-Q · filed 2018-04-25 | ||||||
| 2015-12-31 | -$192.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$244.20M derived: sum of 2 quarters · filed 2018-02-21 | -$1.29B 10-K · filed 2018-02-21 | ||||
| 2015-09-30 | -$51.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$1.10B 10-Q · filed 2016-11-02 | |||||
| 2015-06-30 | -$1.04B 10-Q · filed 2016-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |